Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 17 | 16948752 | stop gained | G/A;C;T | snv | 5.2E-05; 5.6E-05; 1.2E-05 |
|
0.700 | 0 | ||||||||||||
|
0.925 | 0.040 | 17 | 16940375 | stop gained | GG/CC;TT | mnv |
|
0.700 | 0 | ||||||||||||
|
1.000 | 17 | 16972027 | frameshift variant | G/- | delins |
|
0.700 | 0 | |||||||||||||
|
0.851 | 0.080 | 17 | 16940415 | missense variant | G/A;T | snv | 2.8E-05; 5.3E-03 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 0 | ||||||||||
|
0.925 | 0.040 | 17 | 16940352 | missense variant | C/T | snv | 8.0E-04 | 7.5E-04 |
|
0.800 | 1.000 | 1 | 2005 | 2005 | |||||||
|
0.925 | 0.040 | 17 | 16940352 | missense variant | C/T | snv | 8.0E-04 | 7.5E-04 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||
|
0.925 | 0.040 | 17 | 16940375 | stop gained | GG/CC;TT | mnv |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
0.763 | 0.240 | 17 | 16948873 | missense variant | A/G | snv | 3.5E-03 | 3.9E-03 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 1 | 2005 | 2005 | ||||||
|
0.763 | 0.240 | 17 | 16948873 | missense variant | A/G | snv | 3.5E-03 | 3.9E-03 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||
|
0.763 | 0.240 | 17 | 16948873 | missense variant | A/G | snv | 3.5E-03 | 3.9E-03 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
|
0.763 | 0.240 | 17 | 16948873 | missense variant | A/G | snv | 3.5E-03 | 3.9E-03 |
|
Pathological Conditions, Signs and Symptoms; Digestive System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
|
1.000 | 0.080 | 17 | 16972018 | missense variant | G/A;T | snv | 7.2E-05 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.925 | 0.080 | 17 | 16948968 | missense variant | C/T | snv | 2.0E-03 | 2.6E-03 |
|
0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.925 | 0.080 | 17 | 16948968 | missense variant | C/T | snv | 2.0E-03 | 2.6E-03 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
|
0.925 | 0.080 | 17 | 16940465 | stop gained | G/C;T | snv | 4.0E-05 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 17 | 16940465 | stop gained | G/C;T | snv | 4.0E-05 |
|
0.700 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
1.000 | 0.040 | 17 | 16940442 | missense variant | C/T | snv | 1.8E-04 | 2.0E-04 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.851 | 0.080 | 17 | 16940415 | missense variant | G/A;T | snv | 2.8E-05; 5.3E-03 |
|
Immune System Diseases | 0.030 | 1.000 | 3 | 2005 | 2010 | |||||||
|
0.925 | 0.160 | 17 | 16945825 | intron variant | A/G | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.763 | 0.240 | 17 | 16948873 | missense variant | A/G | snv | 3.5E-03 | 3.9E-03 |
|
Immune System Diseases | 0.040 | 1.000 | 4 | 2005 | 2011 | ||||||
|
17 | 16946499 | intron variant | G/C | snv | 0.22 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
17 | 16948713 | intron variant | T/C;G | snv | 8.0E-06; 0.39 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.040 | 17 | 16948892 | synonymous variant | A/C | snv | 4.2E-02 | 3.6E-02 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
17 | 16931972 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
17 | 16948520 | intron variant | C/T | snv | 0.35 |
|
0.700 | 1.000 | 1 | 2012 | 2012 |